Some promising avenues of research focus on CAR T cells designed to target specific molecules like human epidermal growth factor receptor 2 (HER2), EGFRvIII, and alpha receptor 2 of IL-13 (IL-13Rα2) associated with GBM. The gene discussed is ERBB2; the disease is glioblastoma.